Gold tier: mechanically validated evidence, with its primary source.
1,729 evidence items · page 12 / 70
72.1 %Of the 2,739 PLHIV 15 years and above identified in NAIIS, 1,975 (72.1%) were either unaware of their HIV-positive status or were aware but not receiving treatment.
NigeriaVIH/sidaobserved 2018published 2021PloS onePubMeddocument of 13 observations
50 %The prevalence of refractive errors among persons living with HIV/AIDS in Osun State, Nigeria was 50.0%.
Nigeriarefractive errors · VIH/sidapublished 2026BMC ophthalmologyPubMeddocument of 9 observations
99.2 %Among 800 enrolled sexual and gender minorities living with HIV in Nigeria, 99.2% were on antiretroviral therapy.
NigeriaVIH/sidapublished 2023Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 5 observations
14 %HIV seroprevalence in Nigeria among men who have sex with men increased from 14% in 2007 to 23% in 2014.
NigeriaVIH/sidaobserved 2007published 2023AIDS research and therapyPubMed
75.7 %Knowledge of male partners' HIV status was 75.7% among expert mothers versus 66.7% among non-expert mothers.
NigeriaVIH/sidapublished 2020PloS onePubMeddocument of 7 observations
23.9 %HSV-2 prevalence among sexual and gender minorities without HIV-1 in Lagos, Nigeria was 23.9%.
NigeriaHerpes simplex virus type 2 · VIH/sidapublished 2023AIDS research and human retrovirusesPubMeddocument of 3 observations
10.9 %The lowest proportion of downward misclassification for V-DBS was 10.9% at the 1000 copies/mL threshold.
NigeriaVIH/sidapublished 2021Journal of clinical virology : the official publication of the Pan American Society for ClPubMeddocument of 5 observations
23 %Twenty-three percent of the 1442 HIV-1 pol sequences represented unique recombinant forms (URFs).
NigeriaVIH/sidaobserved 1999-2014published 2020Scientific reportsPubMeddocument of 6 observations
49.6 %Of 1745 tested participants, 865 (49.6%) were living with HIV in the TRUST/RV368 cohort in Nigeria.
NigeriaVIH/sidapublished 2020Journal of the International AIDS SocietyPubMeddocument of 8 observations
54 %About 54% of adults adhered to antiretroviral therapy.
NigeriaVIH/sidapublished 2023African health sciencesPubMeddocument of 3 observations
22 %Compared to pre-fee patients, the post-fee period had a 22% decreased risk of loss to follow-up (aRR = 0.64, 95%CI:0.96).
NigeriaVIH/sidapublished 2020PloS onePubMeddocument of 9 observations
2.57 %Among HIV-positive patients aged 31–40 years in the study, the prevalence of HIV/HCV co-infection was 2.57%.
Nigeriahépatite C · VIH/sidaobserved 2019published 2020Journal of immunoassay & immunochemistryPubMeddocument of 9 observations
There was a significant positive correlation between CD4 counts and eosinophil count among HIV-1 individuals.
NigeriaVIH/sidapublished 2020Journal of immunoassay & immunochemistryPubMeddocument of 15 observations
6,926 patientsAmong patients enrolled on antiretroviral therapy from 2004 to 2017, 6,926 (2.8%) died.
NigeriaVIH/sidaobserved 2004 to 2017published 2019AIDS research and therapyPubMeddocument of 11 observations
6.3 %Minor PI resistance-associated mutation L33F was identified in 6.3% of CRF02_AG HIV-1 isolates.
NigeriaVIH/sidapublished 2020PloS onePubMeddocument of 11 observations
2.3 %Between July 2016 and October 2017, 2.3% of male participants at Baby Shower events in Benue State, Nigeria received new HIV-positive diagnoses.
NigeriaVIH/sidaobserved July 2016 to October 2017published 2021PloS onePubMeddocument of 11 observations
17 %Only 17% of the treatment cards had isoniazid prescribed.
NigeriaVIH/sidapublished 2022Malawi medical journal : the journal of Medical Association of MalawiPubMeddocument of 4 observations
130,000 peopleIn Nigeria, 130,000 people were newly infected with HIV.
NigeriaVIH/sidapublished 2022The Pan African medical journalPubMeddocument of 6 observations
3.96 odds_ratioThe odds of macroalbuminuria were higher for participants with the APOL1 high-risk genotype compared to those carrying the low-risk genotype (adjusted odds ratio 3.96, 95% confidence interval 1.95–8.02).
NigeriaVIH/sidapublished 2021Kidney internationalPubMeddocument of 7 observations
90 %Among 10 HBV DNA-positive samples with drug resistance mutations, 90.0% (9/10) were from ART-experienced individuals.
NigeriaVIH/sidaobserved June 2017 to August 2017published 2021Virology journalPubMeddocument of 6 observations
40.9 %The proportion of HIV-positive male partners with adequate PMTCT knowledge was 40.9%.
NigeriaVIH/sidapublished 2020Current HIV researchPubMeddocument of 5 observations
80.3 %Among 300 participants, 241 (80.3%) had voluntarily disclosed their HIV status to someone within their social network.
NigeriaVIH/sidaobserved March to August 2019published 2021Indian journal of public healthPubMeddocument of 3 observations
98.6 %Overall retention to care was 98.6%.
NigeriaVIH/sidaobserved May 2022 to May 2023published 2026BMC public healthPubMeddocument of 9 observations
268 cells_per_mm3The mean CD4 count at enrollment in care was 268 ± 23.7 cells per mm³.
NigeriaVIH/sidapublished 2020AIDS research and therapyPubMeddocument of 12 observations
3.37 aorSpousal HIV-positive status was associated with improved HRQOL (adjusted odds ratio = 3.37, 95% confidence interval: 1.46–7.74).
NigeriaVIH/sidapublished 2020BMC public healthPubMeddocument of 11 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.